The DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.
Mechanisms of normal and tumor-derived angiogenesis
Abstract
Often those diseases most evasive to therapeutic intervention usurp the human body's own cellular machinery or deregulate normal physiological processes for propagation. Tumor-induced angiogenesis is a pathological condition that results from aberrant deployment of normal angiogenesis, an essential process in which the vascular tree is remodeled by the growth of new capillaries from preexisting vessels. Normal angiogenesis ensures that developing or healing tissues receive an adequate supply of nutrients. Within the confines of a tumor, the availability of nutrients is limited by competition among actively proliferating cells, and diffusion of metabolites is impeded by high interstitial pressure (Jain RK. Cancer Res 47: 3039–3051, 1987). As a result, tumor cells induce the formation of a new blood supply from the preexisting vasculature, and this affords tumor cells the ability to survive and propagate in a hostile environment. Because both normal and tumor-induced neovascularization fulfill the essential role of satisfying the metabolic demands of a tissue, the mechanisms by which cancer cells stimulate pathological neovascularization mimic those utilized by normal cells to foster physiological angiogenesis. This review investigates mechanisms of tumor-induced angiogenesis. The strategies used by cancer cells to develop their own blood supply are discussed in relation to those employed by normal cells during physiological angiogenesis. With an understanding of blood vessel growth in both normal and abnormal settings, we are better suited to design effective therapeutics for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This hypoxic stress acts as a potent inducer of angiogenic signaling, upregulating key factors such as vascular endothelial growth factor (VEGF) [51].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [51]
In the citing paper
“As the tumor expands beyond this size, the limited diffusion capacity results in the formation of hypoxic regions, which drive tumor dormancy [50,51].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [51]
In the citing paper
“Instead of triggering angiogenesis, some tumors co-opt existing vasculature and grow along the vessels [53][54][55][56], until the demand for nutrients and oxygen becomes too large and angiogenesis starts again [53,55].”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [53]
In the citing paper
“its presence is essential for initiation of the angiogenic program (76,77)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [76]
In the citing paper
“VEGF-A is the only bona fide endothelial cell growth factor”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [76]
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvořàk, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,969
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Flagged first, then by citations
1 of the 271 references couldn’t be matched to a known paper.
Research works printed but not linked: 32
- Ambs S, 1999, Cancer Res, 59, 5773
- Borgstrom P, 1996, Cancer Res, 56, 4032
- Clark RA, 1996, Am J Pathol, 148, 1407
- Compagni A, 2000, Cancer Res, 60, 7163
- Deroanne CF, 1997, Cancer Res, 57, 5590
- Dumont DJ, 1992, Oncogene, 7, 1471
- Dvorak HF, 1995, Am J Pathol, 146, 1029
- Esser S, 1998, J Cell Sci, 110, 2065
- Folkman J, 1988, Am J Pathol, 130, 393
- Gately S, 1996, Cancer Res, 56, 4887
- Goto F, 1993, Lab Invest, 69, 508
- Healy AM, 1992, Eur J Cell Biol, 59, 56
- Hughes S, 2000, Invest Ophthalmol Vis Sci, 41, 1217
- Jain RK., 1987, Cancer Res, 47, 3039
- Kitsukawa T, 1995, J Biol Chem, 121, 4309
- Kohn S, 1992, Lab Invest, 67, 596
- Korhonen J, 1994, Oncogene, 9, 395
- Luca M, 1997, Am J Pathol, 151, 1105
- Maglione D, 1993, Oncogene, 8, 925
- Merwin JR, 1991, Am J Pathol, 138, 37
- Millauer B, 1996, Cancer Res, 56, 1615
- Nicosia RF, 1994, Am J Pathol, 145, 1023
- Pajusola K, 1992, Cancer Res, 52, 5738
- Pierce GF, 1992, Am J Pathol, 140, 1375
- Senger DR, 1996, Am J Pathol, 149, 293
- Senger DR, 1986, Cancer Res, 46, 5629
- Takahashi Y, 1995, Cancer Res, 55, 3964
- Tanaka T, 1998, Cancer Res, 58, 3362
- Todaro GJ, 1990, Semin Cancer Biol, 1, 257
- Topp MS, 1995, Cancer Res, 55, 2173
- Vlodavsky I, 2000, Isr Med Assoc J, 2, 37
- Ziche M, 1982, J Natl Cancer Inst, 69, 475
Cited by
Sorted by citations
Items 101–200 of 808
Shaik, S., Nucera, C., Inuzuka, H., Gao, D., Garnaas, M., Frechette, G. M., Harris, L. N., Wan, L., Fukushima, H., Husain, A., et al. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20112446 · Cited by 93
Targeting the Angiopoietin-2/Tie-2 axis in conjunction with VEGF signal interference
Biel, N. M., & Siemann, D. W. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.09.035 · Cited by 95
Anti-tumor and Anti-angiogenic Ergosterols from Ganoderma lucidum
Chen, S., Yong, T., Zhang, Y., Su, J., Jiao, C., & Xie, Y. (2017) · Frontiers in Chemistry · doi:10.3389/fchem.2017.00085 · Cited by 92
Biochemical pathways of copper complexes: progress over the past 5 years
Zehra, S., Tabassum, S., & Arjmand, F. (2021) · Drug Discovery Today · doi:10.1016/j.drudis.2021.01.015 · Cited by 92
Ligand-Targeted Delivery of Photosensitizers for Cancer Treatment
Gierlich, P., Mata, A. I., Donohoe, C. L., Brito, R. M. M., Senge, M. O., & Gomes-da-Silva, L. C. (2020) · Molecules · doi:10.3390/molecules25225317 · Cited by 91
αB-crystallin promotes tumor angiogenesis by increasing vascular survival during tube morphogenesis
Dimberg, A., Rylova, S. N., Dieterich, L. C., Olsson, A., Schiller, P., Wikner, C., Bohman, S., Botling, J., Lukinius, A., Wawrousek, E. F., et al. (2007) · Blood · doi:10.1182/blood-2007-04-087841 · Cited by 92
Farokhi, M., Mottaghitalab, F., Ai, J., & Shokrgozar, M. A. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.080 · Cited by 88
Oshi, M., Newman, S., Tokumaru, Y., Yan, L., Matsuyama, R., Endo, I., Nagahashi, M., & Takabe, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186708 · Cited by 89
Kutcher, M., Kolyada, A. Y., Surks, H. K., & Herman, I. M. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.070102 · Cited by 92
Self-citationHereditary Hormone Excess: Genes, Molecular Pathways, and Syndromes
Marx, S. J., & Simonds, W. F. (2005) · Endocrine Reviews · doi:10.1210/er.2003-0037 · Cited by 87
Hughes, G. C., Biswas, S. S., Yin, B., Coleman, R. E., DeGrado, T. R., Landolfo, C. K., Lowe, J. E., Annex, B. H., & Landolfo, K. P. (2004) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2003.09.060 · Cited by 87
Moro, T., Brightwell, C. R., Phalen, D. E., McKenna, C. F., Lane, S. J., Porter, C., Volpi, E., Rasmussen, B. B., & Fry, C. S. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110723 · Cited by 85
Effects of erythropoietin in skin wound healing are dose related
Sorg, H., Krueger, C., Schulz, T., Menger, M. D., Schmitz, F., & Vollmar, B. (2009) · The FASEB Journal · doi:10.1096/fj.08-109991 · Cited by 85
The chick embryo chorioallantoic membrane in the study of tumor angiogenesis.
Ribatti, D. (2008) · PubMed · Cited by 84
CTR1 Silencing Inhibits Angiogenesis by Limiting Copper Entry into Endothelial Cells
Narayanan, G., R., B. S., Vuyyuru, H., Muthuvel, B., & Konerirajapuram Natrajan, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071982 · Cited by 83
New therapeutic targets for cancer bone metastasis
Krzeszinski, J. Y., & Wan, Y. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.04.006 · Cited by 84
Chwalek, K., Bray, L. J., & Werner, C. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.05.006 · Cited by 91
Dendritic Cells The Tumor Microenvironment and the Challenges for an Effective Antitumor Vaccination
Benencia, F., Sprague, L., McGinty, J. W., Pate, M., & Muccioli, M. (2012) · BioMed Research International · doi:10.1155/2012/425476 · Cited by 82
Angiogenesis in Hepatocellular Carcinoma; Pathophysiology, Targeted Therapy, and Role of Imaging
Moawad, A. W., Szklaruk, J., Lall, C. G., Blair, K. J., Kaseb, A. O., Kamath, A., Rohren, S., & Elsayes, K. M. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s224471 · Cited by 81
de Castro, G., Puglisi, F., de Azambuja, E., Saghir, N. S. E., & Awada, A. H. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.007 · Cited by 81
Caputo, R., Tuccillo, C., Manzo, B. A., Zarrilli, R., Tortora, G., Blanco, C. D. V., Ricci, V., Ciardiello, F., & Romano, M. (2003) · PubMed · Cited by 81
Ahmed, S. A., Mendonca, P., Elhag, R. I., & Soliman, K. F. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232416091 · Cited by 86
Antiangiogenic Activity of Ursolic Acid
Manu, K. A., & Kuttan, G. (2010) · Integrative Cancer Therapies · doi:10.1177/1534735410367647 · Cited by 82
Gustavsson, H., Welén, K., & Damber, J. (2004) · The Prostate · doi:10.1002/pros.20145 · Cited by 78
Rgd-Mediated Delivery of Small-Molecule Drugs
Katsamakas, S., Chatzisideri, T., Thysiadis, S., & Sarli, V. (2017) · Future Medicinal Chemistry · doi:10.4155/fmc-2017-0008 · Cited by 82
Zhang, Z. (2006) · World Journal of Gastroenterology · doi:10.3748/wjg.v12.i26.4241 · Cited by 78
During, M. J., Liu, X., Huang, W., Magee, D., Slater, A., McMurphy, T. B., Wang, C., & Cao, L. (2015) · Endocrinology · doi:10.1210/en.2014-1905 · Cited by 81
Regulation of VEGF-A in Uveal Melanoma
el Filali, M., Missotten, G. S., Maat, W., Ly, L. V., Luyten, G. P. M., van der Velden, P. A., & Jager, M. J. (2010) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-4739 · Cited by 77
Rocha, L. A., Learmonth, D. A., Sousa, R. A., & Salgado, A. J. (2017) · Biotechnology Advances · doi:10.1016/j.biotechadv.2017.11.004 · Cited by 78
Molecular basis of therapeutic approaches to gastric cancer
Wu, K., Nie, Y., Guo, C., Chen, Y., Ding, J., & Fan, D. (2009) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2008.05753.x · Cited by 75
Anti-angiogenic gene therapy of cancer: Current status and future prospects
Persano, L., Crescenzi, M., & Indraccolo, S. (2007) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.12.005 · Cited by 75
Tumor vascular targeting therapy with viral vectors
Liu, Y., & Deisseroth, A. (2005) · Blood · doi:10.1182/blood-2005-10-4114 · Cited by 74
Roles of Non-coding RNAs and Angiogenesis in Glioblastoma
Balandeh, E., Mohammadshafie, K., Mahmoudi, Y., Pourhanifeh, M. H., Rajabi, A., Bahabadi, Z. R., Mohammadi, A. H., Rahimian, N., Hamblin, M. R., & Mirzaei, H. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.716462 · Cited by 74
Recapitulating the vasculature using ORGAN-ON-CHIP technology
Pollet, A. M. A. O., & den Toonder, J. M. J. (2020) · Bioengineering · doi:10.3390/bioengineering7010017 · Cited by 73
How VEGF-A and its splice variants affect breast cancer development – clinical implications
Kawas, H. A., Saaid, I., Jank, P., Westhoff, C. C., Denkert, C., Pross, T., Weiler, K. B. S., & Karsten, M. M. (2022) · Cellular Oncology · doi:10.1007/s13402-022-00665-w · Cited by 72
Osteochondral plate angiogenesis: A new treatment target in osteoarthritis
Pesesse, L., Sanchez, C., & Henrotin, Y. E. (2010) · Joint Bone Spine · doi:10.1016/j.jbspin.2010.07.001 · Cited by 72
Human stem cells expressing novel TSP-1 variant have anti-angiogenic effect on brain tumors
van Eekelen, M., Sasportas, L. S., Kasmieh, R., Yip, S. S. F., Figueiredo, J.-L., Louis, D. N., Weissleder, R., & Shah, K. (2010) · Oncogene · doi:10.1038/onc.2010.75 · Cited by 72
Lambert, C., Mathy-Hartert, M., Dubuc, J., Montell, E., Vergés, J., Munaut, C., Noël, A., & Henrotin, Y. E. (2012) · Arthritis Research & Therapy · doi:10.1186/ar3771 · Cited by 73
Satapathy, S. R., Nayak, A., Siddharth, S., Das, S., Nayak, D., & Kundu, C. N. (2018) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.01.007 · Cited by 70
Lee, S., Zeiger, A. S., Maloney, J. M., Kotecki, M., Vliet, K. J. V., & Herman, I. M. (2010) · Journal of Physics Condensed Matter · doi:10.1088/0953-8984/22/19/194115 · Cited by 71
Self-citationInhibition of angiogenesis in human endothelial cell using VEGF specific nanobody
Kazemi‐Lomedasht, F., Behdani, M., Bagheri, K. P., Habibi‐Anbouhi, M., Abolhassani, M., Arezumand, R., Shahbazzadeh, D., & Mirzahoseini, H. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2015.01.010 · Cited by 70
Cancer models, genomic instability and somatic cellular Darwinian evolution
Little, M. P. (2010) · Biology Direct · doi:10.1186/1745-6150-5-19 · Cited by 69
Plank, M. J., Sleeman, B. D., & Jones, P. F. (2004) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2004.04.012 · Cited by 70
Berberine Inhibits HIF-1α Expression via Enhanced Proteolysis
Lin, S., Tsai, S.-C., Lee, C.-C., Wang, B.-W., Liou, J.-Y., & Shyu, K. (2004) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)05644-x · Cited by 70
Rezzola, S., Loda, A., Corsini, M., Semeraro, F., Annese, T., Presta, M., & Ribatti, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.581288 · Cited by 75
Ghilardi, C., Chiorino, G., Dossi, R., Nagy, Z., Giavazzi, R., & Bani, M. R. (2008) · BMC Genomics · doi:10.1186/1471-2164-9-201 · Cited by 69
Kuo, S., Ke, F., Chang, G., Lee, M., & Hwang, J. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22491 · Cited by 69
Cooperative Effects of Vascular Angiogenesis and Lymphangiogenesis
Osaki, T., Serrano, J. C., & Kamm, R. D. (2018) · Regenerative Engineering and Translational Medicine · doi:10.1007/s40883-018-0054-2 · Cited by 69
Endothelial α1‐adrenoceptors regulate neo‐angiogenesis
Ciccarelli, M., Santulli, G., Campanile, A., Galasso, G., Cervero, P., Altobelli, G. G., Cimini, V., Pastore, L., Piscione, F., Trimarco, B., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707637 · Cited by 68
Kumar, V., & Varghese, S. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801198 · Cited by 73
Li, M., Wu, S., Liu, Z., Zhang, W., Xu, J., Wang, Y., Liu, J., Zhang, D., Tian, H., Li, Y.-L., et al. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.01.023 · Cited by 67
Low, L. E., Wu, J., Lee, J., Tey, B. T., Goh, B. H., Gao, J., Li, F., & Ling, D. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.05.014 · Cited by 67
Angiogenesis in Nervous System Disorders
Zadeh, G. M., & Guha, A. (2003) · Neurosurgery · doi:10.1227/01.neu.0000093425.98136.31 · Cited by 66
Shah, S., & D’Souza, G. G. M. (2025) · Cells · doi:10.3390/cells14100732 · Cited by 83
Cancer-on-chip models for metastasis: importance of the tumor microenvironment
Jouybar, M., de Winde, C. M., Wolf, K., Friedl, P., Mebius, R. E., & den Toonder, J. M. J. (2024) · Trends in Biotechnology · doi:10.1016/j.tibtech.2023.10.001 · Cited by 66
An endothelial link between the benefits of physical exercise in dementia
Trigiani, L. J., & Hamel, É. (2017) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x17714655 · Cited by 69
Karagiannis, E. D., & Popel, A. S. (2005) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2005.05.020 · Cited by 65
Angiogenesis: From Chronic Liver Inflammation to Hepatocellular Carcinoma
Sanz-Cameno, P., Trapero-Marugán, M., Chaparro, M., Jones, E. A., & Moreno‐Otero, R. (2010) · Journal of Oncology · doi:10.1155/2010/272170 · Cited by 64
Chaparro, M., MORENO, L. G., Trapero-Marugán, M., MEDINA, J., & Moreno‐Otero, R. (2008) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03857.x · Cited by 63
MicroRNAs: Promising New Antiangiogenic Targets in Cancer
Gallach, S., Fariñas, S. C., Lewintre, E. J., & Camps, C. (2014) · BioMed Research International · doi:10.1155/2014/878450 · Cited by 64
Cyclic strain modulates tubulogenesis of endothelial cells in a 3D tissue culture model
Joung, I. S., Iwamoto, M., Shiu, Y.-T. E., & Quam, C. T. (2005) · Microvascular Research · doi:10.1016/j.mvr.2005.10.005 · Cited by 63
A study on biomarkers, cytokines, and growth factors in children with burn injuries.
Abdel-Hafez, N. M., Hassan, Y., & El‐Metwally, T. H. (2007) · PubMed Central · Cited by 62
Toh, H., Cao, M., Daniels, E., & Bateman, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064989 · Cited by 62
Targeting Angiogenesis in Cancer Treatments: Where do we Stand?
Petrovic, N. (2016) · Journal of Pharmacy & Pharmaceutical Sciences · doi:10.18433/j30033 · Cited by 62
Zhu, L., Li, M., Liu, X., Du, L., & Jin, Y. (2016) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2016.09.006 · Cited by 62
Kisand, K., Tamm, A. E., Lintrop, M., & Tamm, A. O. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.05.009 · Cited by 62
Julio‐Pieper, M., Lozada, P., Tapia, V. M., Vega, M., Miranda, C., Vantman, D., Ojeda, S. R., & Romero, C. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0542 · Cited by 61
Dixelius, J., Jakobsson, L., Genersch, E., Bohman, S., Ekblom, P., & Claesson, L. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m311675200 · Cited by 61
Netrins and UNC5 receptors in angiogenesis
Freitas, C., Larrivée, B., & Eichmann, A. (2008) · Angiogenesis · doi:10.1007/s10456-008-9096-2 · Cited by 63
Engineering of synthetic intercellular communication systems
Bacchus, W., & Fussenegger, M. (2012) · Metabolic Engineering · doi:10.1016/j.ymben.2012.12.001 · Cited by 60
Vessel-on-a-chip models for studying microvascular physiology, transport, and function in vitro
Moses, S. R., Adorno, J. J., Palmer, A. F., & Song, J. W. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00355.2020 · Cited by 61
Zalpoor, H., Aziziyan, F., Liaghat, M., Bakhtiyari, M., Akbari, A., Nabi‐Afjadi, M., Forghaniesfidvajani, R., & Rezaei, N. (2022) · Cell Communication and Signaling · doi:10.1186/s12964-022-00951-y · Cited by 63
Sharma, A. V., Ganguly, K., Paul, S., Maulik, N., & Swarnakar, S. (2011) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4232 · Cited by 60
Angiotensin receptor blockers and angiogenesis: clinical and experimental evidence
Willis, L., El‐Remessy, A. B., Somanath, P. R., DeRemer, D. L., & Fagan, S. C. (2010) · Clinical Science · doi:10.1042/cs20100389 · Cited by 61
Paying attention to tumor blood vessels: Cancer phototherapy assisted with nano delivery strategies
Yang, S., Chen, C., Qiu, Y., Xu, C., & Yao, J. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120562 · Cited by 60
Mouse models for colorectal cancer.
Karim, B. O., & Huso, D. L. (2013) · Europe PMC (PubMed Central) · Cited by 58
Ma, E., Li, Y., Tsuneki, H., Xiao, J., Xia, M., Wang, M., & Kimura, I. (2008) · Journal of Asian Natural Products Research · doi:10.1080/10286020701394332 · Cited by 59
Vascular Complications and Diabetes: Current Therapies and Future Challenges
Willard, A. L., & Herman, I. M. (2012) · Journal of Ophthalmology · doi:10.1155/2012/209538 · Cited by 61
Self-citationAndrogen deprivation induces rapid involution and recovery of human prostate vasculature
Godoy, A., Montecinos, V. P., Gray, D. R., Sotomayor, P. C., Yau, J. M., Vethanayagam, R. R., Singh, S. S., Mohler, J. L., & Smith, G. J. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00210.2010 · Cited by 59
Medeiros, P. J., & Jackson, D. N. (2013) · Peptides · doi:10.1016/j.peptides.2013.07.029 · Cited by 59
Screening and identification of vascular-endothelial-cell-specific binding peptide in gastric cancer
Liang, S., Lin, T., Ding, J., Pan, Y., Dang, D., Guo, C., Zhi, M., Zhao, P., Sun, L. J., Hong, L., et al. (2006) · Journal of Molecular Medicine · doi:10.1007/s00109-006-0064-2 · Cited by 58
Fernández-Alonso, R., Martín‐López, M., González-Cano, L., Garcia, S., Castrillo, F., Diez-Prieto, I., Fernández‐Corona, A., Lorenzo-Marcos, M. E., Li, X., Claesson, L., et al. (2015) · Cell Death and Differentiation · doi:10.1038/cdd.2014.214 · Cited by 58
The αvβ6 integrin in cancer cell‐derived small extracellular vesicles enhances angiogenesis
Krishn, S. R., Salem, I., Quaglia, F., Naranjo, N. M., Agarwal, E., Liu, Q., Sarker, S., Kopenhaver, J. S., McCue, P. A., Weinreb, P. H., et al. (2020) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2020.1763594 · Cited by 58
Sinusas, A. J. (2004) · Journal of Nuclear Cardiology · doi:10.1016/j.nuclcard.2004.07.001 · Cited by 57
He, J., Liu, Z., Zhu, X., Xia, H., Gao, H., & Lu, J. G. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081642 · Cited by 56
Aptamer-based analysis of angiogenin by fluorescence anisotropy
Li, W., Wang, K., Tan, W., Ma, C., & Yang, X. (2006) · The Analyst · doi:10.1039/b614138b · Cited by 56
Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
Alexandrakis, M. G., Goulidaki, N., Pappa, C. A., Boula, A., Psarakis, F. E., Neonakis, I., & Tsirakis, G. (2015) · Pathology & Oncology Research · doi:10.1007/s12253-015-9921-z · Cited by 56
Angiogenesis: Future of pharmacological modulation
Bisht, M., Dhasmana, D. C., & Bist, S. (2010) · Indian Journal of Pharmacology · doi:10.4103/0253-7613.62395 · Cited by 56
Gene therapy delivery of endostatin enhances the treatment efficacy of radiation
Shi, W., Teschendorf, C., Muzyczka, N., & Siemann, D. W. (2003) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(02)00280-3 · Cited by 56
Yu, T., Wang, Y., Chen, P., Li, Y.-H., Chen, Y.-X., Zeng, H., Yu, A., Huang, M., & Bi, H.-C. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000369731 · Cited by 55
Nicotine: A pro-angiogenic factor
Costa, F., & Soares, R. A. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.03.002 · Cited by 53
MiR-19b-1 inhibits angiogenesis by blocking cell cycle progression of endothelial cells
Yin, R., Bao, W., Xing, Y., Xi, T., & Gou, S. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.12.032 · Cited by 55
Pourgholami, M. H., Khachigian, L. M., Fahmy, R. G., Badar, S., Wang, L. E., Chu, S. W. L., & Morris, D. L. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.06.019 · Cited by 55
Inhibition of lung cancer cell proliferation mediated by human mesenchymal stem cells
Li, L., Tian, H., Chen, Z., Yue, W., Li, S., & Li, W. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmq118 · Cited by 54
Pan, R., Dai, Y., Gao, X., Lü, D., & Xia, Y. (2010) · Vascular Pharmacology · doi:10.1016/j.vph.2010.11.001 · Cited by 54
Paschoalin, T., Carmona, A. K., Rodrigues, E. G., Oliveira, V., Monteiro, H. P., Juliano, M. A., Juliano, L., & Travassos, L. R. (2007) · Molecular Cancer · doi:10.1186/1476-4598-6-44 · Cited by 54
Antiangiogenic mechanisms and factors in breast cancer treatment
Vishwanatha, J. K., & Castañeda-Gill, J. (2016) · Journal of Carcinogenesis · doi:10.4103/1477-3163.176223 · Cited by 54
Kim, A., Im, M., Yim, N., & Yeul, J. (2014) · Scientific Reports · doi:10.1038/srep06994 · Cited by 53
Julio‐Pieper, M., Lara, H. E., Bravo, J. A., & Romero, C. (2006) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-4-57 · Cited by 53
Zhu, L., Li, M., Liu, X., & Jin, Y. (2017) · ACS Omega · doi:10.1021/acsomega.7b00456 · Cited by 53
Metadata
- Authors
- Papetti, M., & Herman, I. M.
- Affiliations
- Tufts University (US)
- ORCID
- Herman, Ira M.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2002-05-01
- Volume
- 282
- Issue
- 5
- Pages
- C947-C970
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2050499474
- Cited by
- 809
- References
- 271
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 19 · 2023: 33 · 2022: 38 · 2021: 32 · 2020: 36 · 2019: 28 · 2018: 20 · 2017: 41 · 2016: 36 · 2015: 45 · 2014: 42 · 2013: 46 · 2012: 41
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Cell Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm055110-04)
- National Eye Institute (R01EY009033, EY09033)
- National Institute of General Medical Sciences (GM55110)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034928)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor angiogenesis, physiological angiogenesis, tumor blood supply, vascular remodeling, capillary proliferation, interstitial fluid pressure, tumor microenvironment, cancer metabolism
- MeSH terms
- Blood Vessels, Growth Substances, Humans, Models, Cardiovascular, Neoplasms, Neovascularization, Pathologic, Proteins, Receptors, Cell Surface, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Angiopoietin-2, Receptors, TIE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review